AI assistant
UNITED THERAPEUTICS Corp — Director's Dealing 2014
Mar 27, 2014
30320_dirs_2014-03-27_e00b1e35-8571-4b30-aece-f41670fb8fc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2014-03-27
Reporting Person: ROTHBLATT MARTINE A (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-27 | Common Stock | M | 3833 | $34.56 | Acquired | 3973 | Direct |
| 2014-03-27 | Common Stock | S | 3833 | $94.7889 | Disposed | 140 | Direct |
| 2014-03-27 | Common Stock | M | 5233 | $30.75 | Acquired | 5373 | Direct |
| 2014-03-27 | Common Stock | S | 5133 | $92.2659 | Disposed | 240 | Direct |
| 2014-03-27 | Common Stock | S | 100 | $93.48 | Disposed | 140 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-27 | Stock Options | $34.56 | M | 3833 | Disposed | 2015-12-30 | Common Stock (3833) | Direct |
| 2014-03-27 | Stock Options | $30.75 | M | 5233 | Disposed | 2017-12-31 | Common Stock (5233) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 166 | Indirect |
| Common Stock | 533094.05 | Indirect |
Footnotes
F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
F3: This transaction was executed in multiple trades at prices ranging from $94.41 to $95.092. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $92.25 to $92.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.